Orion Portfolio Solutions LLC Sells 753 Shares of Colgate-Palmolive (NYSE:CL)

Orion Portfolio Solutions LLC lessened its position in Colgate-Palmolive (NYSE:CLFree Report) by 1.7% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 43,297 shares of the company’s stock after selling 753 shares during the period. Orion Portfolio Solutions LLC’s holdings in Colgate-Palmolive were worth $4,495,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of CL. Continuum Advisory LLC raised its holdings in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after acquiring an additional 125 shares during the period. Reston Wealth Management LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive in the 3rd quarter worth $53,000. Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the 3rd quarter worth $64,000. Finally, Gradient Investments LLC raised its holdings in Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after acquiring an additional 400 shares during the period. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.37% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CL. Piper Sandler began coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 price target on the stock. Deutsche Bank Aktiengesellschaft lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their price target for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. UBS Group raised their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Finally, TD Cowen decreased their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $105.11.

Check Out Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Price Performance

NYSE:CL opened at $92.95 on Tuesday. The firm has a market cap of $75.94 billion, a PE ratio of 26.63, a price-to-earnings-growth ratio of 3.36 and a beta of 0.43. Colgate-Palmolive has a 12 month low of $75.50 and a 12 month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company’s 50-day moving average price is $96.33 and its two-hundred day moving average price is $98.65.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.